Praxis Precision Medicines Announces Positive Phase 2 Results for Vormatrigine in Focal Onset Seizures

Praxis Precision Medicines announced positive topline results from the Phase 2 RADIANT study of vormatrigine in patients with focal onset seizures. T...

Empowering Life Sciences with
Advanced AI Solutions.

Book A Demo
HomeKnolsightsContact UsPricing
One Research Ct, Suite 450 Rockville, MD, 20850
info@pienomial.com
+91 9876543210
Copyright © 2025. All rights reserved
AboutTerms of ServicePrivacy Policy
Home/KnloSights/Clinical Trial Updates/Praxis Precision Medicines Announces Positive Phase 2 Results for Vormatrigine in Focal Onset Seizures